Related Experiment Videos

Gout, just a nasty event or a cardiovascular signal? A study from primary care

H J E M Janssens1, E H van de Lisdonk, H Bor

  • 1University Medical Centre, Department of General Practice and Family Medicine 229, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

Family Practice
|July 24, 2003
PubMed

Insights

Gout is linked to cardiovascular diseases and risk factors like hypertension and obesity. However, gout itself is not an independent predictor of cardiovascular disease development.

Area of Science:

  • Cardiology
  • Rheumatology
  • General Practice

Background:

  • Gout is a common inflammatory arthritis characterized by hyperuricemia.
  • Cardiovascular diseases (CVD) are a leading cause of morbidity and mortality worldwide.
  • The relationship between gout and CVD requires further investigation.

Purpose of the Study:

  • To investigate the association between gout and cardiovascular diseases.
  • To examine the link between gout and cardiovascular risk indicators.

Main Methods:

  • A case-control study involving 261 gout patients and 522 matched controls from Dutch general practices.
  • Follow-up study to assess the incidence of cardiovascular morbidity in gout patients.
  • Outcome measures included prevalence and incidence of cardiovascular diseases, hypertension, diabetes mellitus, obesity, and hypercholesterolemia.

Main Results:

  • Gout patients exhibited a higher prevalence of prevalent cardiovascular diseases compared to controls.
  • Patients with gout showed significantly higher rates of hypertension, hypercholesterolemia, and obesity.
  • Gout was not identified as an independent determinant for the development of cardiovascular disease after adjusting for risk factors.

Conclusions:

  • Gout is associated with cardiovascular diseases and risk indicators.
  • Gout itself is not an independent risk factor for developing cardiovascular disease.
  • A gout diagnosis warrants a comprehensive assessment of a patient's cardiovascular risk profile.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...